NCT02863523

Brief Summary

The study will implement and evaluate, using a pragmatic comparative effectiveness trial, a unique collaborative, stepped-care intervention for patients with uncontrolled Type 2 diabetes and co-morbid distress and/or depression.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
139

participants targeted

Target at P50-P75 for not_applicable type-2-diabetes-mellitus

Timeline
Completed

Started Sep 2014

Typical duration for not_applicable type-2-diabetes-mellitus

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

August 3, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 11, 2016

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
6 years until next milestone

Results Posted

Study results publicly available

December 8, 2023

Completed
Last Updated

December 8, 2023

Status Verified

March 1, 2023

Enrollment Period

3.3 years

First QC Date

August 3, 2016

Results QC Date

February 14, 2019

Last Update Submit

March 10, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change From Baseline in Glycosylated Hemoglobin (%)

    Change from baseline in HbA1c or glycosylated hemoglobin (%)

    Baseline to 12 months

Secondary Outcomes (1)

  • Change From Baseline in Diabetes Regimen-Related Distress

    Baseline to 12 months

Other Outcomes (2)

  • Change in Diabetes Self-care Activities

    Baseline to 12 months

  • Change in Depressive Symptoms

    Baseline to 12 months

Study Arms (2)

Integrated Behavioral Intervention

EXPERIMENTAL

Patients receive intensive behavioral counseling that may include elements of cognitive behavioral therapy, problem solving therapy, and small changes lifestyle counseling in addition to medical care.

Behavioral: Integrated Behavioral Care

Usual Care

NO INTERVENTION

Patients receive usual care

Interventions

Patients receive intensive behavioral counseling that may include elements of cognitive behavioral therapy, problem solving therapy, and small changes lifestyle counseling in addition to medical care.

Integrated Behavioral Intervention

Eligibility Criteria

Age19 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical Diagnosis of Type 2 diabetes mellitus
  • Glycosylated Hemoglobin (HbA1c) \> 7.0 = Uncontrolled
  • Positive score on diabetes related distress 2 question screener and/or
  • Positive score on Patient Health Questionnaire (PHQ-2) 2 question screener

You may not qualify if:

  • advanced disease (e.g., end stage renal disease, advanced heart failure, blindness, metastatic cancer and including those who are in active treatment for cancer), or
  • alcoholism or
  • cognitive impairment, or
  • major psychiatric disease or
  • any type of physical or mental impairment that would preclude active participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

East Carolina University

Greenville, North Carolina, 27834, United States

Location

Related Publications (3)

  • Cummings DM, Lutes LD, Littlewood K, Solar C, Carraway M, Kirian K, Patil S, Adams A, Ciszewski S, Edwards S, Gatlin P, Hambidge B. Randomized Trial of a Tailored Cognitive Behavioral Intervention in Type 2 Diabetes With Comorbid Depressive and/or Regimen-Related Distress Symptoms: 12-Month Outcomes From COMRADE. Diabetes Care. 2019 May;42(5):841-848. doi: 10.2337/dc18-1841. Epub 2019 Mar 4.

    PMID: 30833367BACKGROUND
  • Lutes LD, Cummings DM, Littlewood K, Le MT, Kirian K, Patil S, Solar C, Carraway M, Hambidge B. A Tailored Cognitive-Behavioural Intervention Produces Comparable Reductions in Regimen-Related Distress in Adults With Type 2 Diabetes Regardless of Insulin Use: 12-Month Outcomes From the COMRADE Trial. Can J Diabetes. 2020 Aug;44(6):530-536. doi: 10.1016/j.jcjd.2020.05.016. Epub 2020 Jun 10.

    PMID: 32792107BACKGROUND
  • Lutes LD, Cummings DM, Littlewood K, Solar C, Carraway M, Kirian K, Patil S, Adams A, Ciszewski S, Hambidge B. COMRADE: A randomized trial of an individually tailored integrated care intervention for uncontrolled type 2 diabetes with depression and/or distress in the rural southeastern US. Contemp Clin Trials. 2018 Jul;70:8-14. doi: 10.1016/j.cct.2018.04.007. Epub 2018 Apr 20.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Depression

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavioral SymptomsBehavior

Limitations and Caveats

Adverse event detection was limited to events potentially associated with behavioral counseling.

Results Point of Contact

Title
Dr. Doyle Cummings
Organization
East Carolina University

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Family Medicine

Study Record Dates

First Submitted

August 3, 2016

First Posted

August 11, 2016

Study Start

September 1, 2014

Primary Completion

December 1, 2017

Study Completion

December 1, 2017

Last Updated

December 8, 2023

Results First Posted

December 8, 2023

Record last verified: 2023-03

Locations